Besifloxacin is a recently approved for the topical treatment of bacterial conjunctivitis fluoroquinolone drugs.

June 21, 2017

prudect name : Besifloxacin is a recently approved for the topical treatment of bacterial conjunctivitis fluoroquinolone drugs.
Besifloxacin

Synonyms: CAS NO: 141388-76-3Molecular Formula: C₁₉H₂₁ClFN₃O₃Molecular Weight: 393.84Purity: 99%Solubility: Storage: −20°C 2 years

INNO-406 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/1850549